| Subject: | FDA Guidance on Differences between C-Reactive Protein (CRP) Assays |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Mon, 20 Mar 2006 - 10:00 am |
| The FDA has issued communication to provide information about the differences of conventional CRP, high sensitivity CRP (hsCRP) and cardiac CRP (cCRP) assays and the regulatory need to designate a CRP assay specifically for cardiovascular risk indications for use. Apparently there is some confusion in the laboratory community, from clinicians and from manufacturers on the indications for use of different C-Reactive Protein (CRP) assays.
C-Reactive Protein Assays Indications for Use:... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
REFERENCES:
Policies / Forms / Additional Resources:
Additional Tools Related to This Topic:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. Currently StayAlert! is the leader in the comprehensive compliance information marketplace. Why? Because StayAlert! provides healthcare professionals with more than information. StayAlert! provides a service, in many cases "doing the work" for you, and assisting regulatory compliance officers to effectively and efficiently meet changing standards. |
|
